Yibin Kang, a founding member of the Ludwig Institute for Cancer Research Princeton Branch, is a Warner-Lambert/Parke-Davis Professor of Molecular Biology at Princeton University, and an associate director of Rutgers Cancer Institute of New Jersey. Kang graduated with a bachelor’s degree from Fudan University in Shanghai in 1995. After completing his graduate study at Duke University in 2000 and postdoctoral training with Dr. Joan Massagué at the Memorial Sloan-Kettering Cancer Center, he joined the faculty of Princeton University as an assistant professor of molecular biology in 2004. He was promoted to associate professor with tenure in 2010 and to endowed chair full professor in 2012. Kang has served as the president of the Metastasis Research Society (2016-2018), the chair of the American Association for Cancer Research (AACR) Tumor Microenvironment Working Group (2018-2019), and president of the Chinese Biological Investigator Society (2018-2022).
Kang’s research focuses on the molecular mechanisms of breast cancer metastasis. His work discovered new genes that promote recurrence, metastasis, immune evasion and chemoresistance of breast cancer, delineated tumor-stromal interactions that are essential for metastatic growth, identified novel regulators of mammary gland cell fate determination and tumor progression and developed new cancer therapeutic agents. He has published over 180 original articles in leading journals including Science, Cancer Cell, Nature Cell Biology, Nature Cancer and Nature Medicine. Kang's outstanding achievements have been recognized by many prestigious awards, including an American Cancer Society Research Scholar Award (2005), Department of Defense Era of Hope Scholar Award (2006), the 2011 Vilcek Prize for Creative Promise in Biomedical Sciences (2011), the American Association for Cancer Research (AACR) Award for Outstanding Achievements in Cancer Research (2012), the Fidler Innovation Award from the Metastasis Research Society (2014), the Fuller Albright Award from the American Society for Bone and Mineral Research (2014) and the AACR Outstanding Investigator Award in Breast Cancer Research (2014). Professor Kang was elected as a fellow of the American Association for the Advancement of Science (AAAS). He is a Komen Scholar and an inaugural inductee of the Duke Graduate School Few-Glasson Alumni Society in 2016. In 2019, he was selected as an American Cancer Society Research Professor.